Education
About Us
Working with TipRanks
Follow Us
Beyond Air Inc (XAIR)
NASDAQ:XAIR
XAIR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.24 - $1.78
Previous CloseN/A
Volume845.14K
Average Volume (3M)1.28M
Market Cap
$26.01M
Enterprise Value$31.85M
Total Cash (Recent Filing)$4.60M
Total Debt (Recent Filing)$2.01M
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Jul 01, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding88,278,650
10 Day Avg. Volume1,519,836
30 Day Avg. Volume1,281,478
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.83
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market Cap1.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-24.37
Enterprise Value/Ebitda-0.66
Forecast
1Y Price Target
$1.33Price Target Upside375.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Beyond Air News
PremiumCompany Announcements
Beyond Air Expands Global Reach for LungFit PH
PremiumCompany Announcements
Beyond Air’s Earnings Call: Growth and Challenges
PremiumCompany Announcements
Beyond Air’s Revenue Growth and Global Expansion
PremiumPre-Earnings
Is XAIR a Buy, Before Earnings?
PremiumCompany Announcements
Beyond Air Granted Extension to Meet Nasdaq Requirements---
Bulls Say, Bears Say
Bulls Say
Market ExpansionLungFit PH received CE Mark in Europe and Market Authorization, opening new markets for the company.
RevenueLungFit PH revenue of $1.1M exceeded estimates and showed significant growth quarter-over-quarter and year-over-year.
Bears Say
Cash BurnCash burn is expected to continue, albeit at a lower rate, due to planned submission activities.
Initial SetbacksThe company faced challenges in its initial commercial efforts, limiting its ability to achieve substantial revenue.
---
Ownership Overview
15.72% Insiders
1.88% Mutual Funds
15.90% Other Institutional Investors
64.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XAIR FAQ
What was Beyond Air Inc’s price range in the past 12 months?
Beyond Air Inc lowest stock price was $0.24 and its highest was $1.78 in the past 12 months.
What is Beyond Air Inc’s market cap?
Beyond Air Inc’s market cap is $26.01M.
When is Beyond Air Inc’s upcoming earnings report date?
Beyond Air Inc’s upcoming earnings report date is Jul 01, 2025 which is in 94 days.
How were Beyond Air Inc’s earnings last quarter?
Beyond Air Inc released its earnings results on Feb 10, 2025. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.159 by $0.009.
Is Beyond Air Inc overvalued?
According to Wall Street analysts Beyond Air Inc’s price is currently Undervalued.
Does Beyond Air Inc pay dividends?
Beyond Air Inc does not currently pay dividends.
What is Beyond Air Inc’s EPS estimate?
Beyond Air Inc’s EPS estimate is -0.12.
How many shares outstanding does Beyond Air Inc have?
Beyond Air Inc has 88,278,650 shares outstanding.
What happened to Beyond Air Inc’s price movement after its last earnings report?
Beyond Air Inc reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.159. Following the earnings report the stock price went down -6.818%.
Which hedge fund is a major shareholder of Beyond Air Inc?
Currently, no hedge funds are holding shares in XAIR
---
Beyond Air Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1.33 (375.00% Upside)
$1.33 (375.00% Upside)
Hedge Fund Trend
Decreased
By 476.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $252.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.60%
12-Months-Change
Fundamentals
Return on Equity
-271.97%
Trailing 12-Months
Asset Growth
-34.23%
Trailing 12-Months
Company Description
Beyond Air Inc
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
---
XAIR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Beyond Air reported strong sequential revenue growth and international expansion, supported by reduced expenses and strategic partnerships. However, the company continues to face challenges with gross profit loss, net losses, onetime costs, and regulatory uncertainties.Read More>---
XAIR Stock 12 Month Forecast
Average Price Target
$1.33
▲(375.00% Upside)
Technical Analysis
Best Analysts Covering XAIR
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-57.34%
reiterated a buy rating 2 months ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -57.34% per trade.
---